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1. Introduction 
Fusidic acid is a well known inhibitor of both 
prokaryotic and eukaryotic protein synthesis [ 11. It 
interferes with the elongation of the peptide chain by 
interacting with the translocation factor, forming an 
EF-G-GDP-ribosome-fusidic acid complex [2-41. 
The working mechanism has been under discussion 
continuously. Several modes of action have been propos. 
ed: inhibition of translocation of peptidyl-tRNA and 
subsequent release of deacylated tRNA from the 
donor site [5-91, inhibition of the translocation after 
one additional translocation step [4,10], and on the 
other hand the inhibition of binding of aminoacyl- 
tRNA to the ribosomal acceptor site [IO-131 . These 
at first sight contradictory findings were reconciliated 
by the discovery that there is only one binding site for 
aminoacyl-tRNA (bound enzymatically or non-enzy- 
matically) and EF-G. There is now a vast amount of 
evidence both for prokaryotic ribosomes [ 14- 191 and 
eukaryotic ones [20-221 that EF-Tu(EF-1) and 
EF-G(EF-2) interact in a mutually exclusive fashion 
with ribosomes. Thus fusidic acid stabilized binding of 
the translocatiqn factor to ribosomes inhibits the 
subsequent binding of aminoacyl-tRNA. 
However, another complication in the use of fusidic 
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acid seems to be the dependence on the relative 
amounts of fusidic acid, of EF-G(EF-2) and of riboso- 
mes present in the incubation mixture [20,23,24]. If 
too less fusidic acid or free ribosomes are present to 
trap all EF-G (or EF-2) in an EF-G-GDP-ribosome- 
fusidic acid complex, the not sequestered EF-G can 
continue to catalyze translocation reactions. 
In this paper we present evidence, that fusidic acid 
inhibits the reaction between puromycin and donor 
site-bound N-AC- [ l4 C] Phe-tRNA too. This effect of 
fusidic acid has not been reported until1 now. 
2. Methods 
Sources of reagents and methods for preparing yeast 
ribosomal subunits, N-AC- [I 4 C] Phe-tRNA, enzyme 
fractions, treatment of EF-2 with diphtheria toxin and 
incubations were essentially as described previously 
[25,26]. 
3. Results 
When N-AC-[’ 4 C] Phe-tRNA is bound non-enzyma- 
tically to yeast ribosomes, addition of EF-2 leads to 
an additional binding of N-Ac-[14C] Phe-tRNA, which 
is inhibited by fusidic acid or pretreatment of EF-2 
with diphtheria toxin (table 1). We have explained 
this finding by assuming that, after translocation, the 
acceptor sites of the ribosomes had become available 
for the additional binding of N-AC [ I4 C] Phe-tRNA 
WI. 
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Table 1 
EF-2 mediated binding of IV-AC-]’ 4 C ] Phe-tRNA in a pyromycin-reactive state and 
inhibition by fusidic acid of N-Ac-[“Cl Phe-puromycin formation 
Exp. 
1. 
2. 
3. 
4. 
5. 
Additions 
Molecules bound 
lSt step 2nd step 
Molecules released by 
per ribosome puromycin per ribosome 
___.__ 
none none 0.27 0.06 
EF-2 none 0.50 0.19 
EF-2(inacti- none 0.28 0.06 
vated by 
diphtheria 
toxin) 
EF-2+2 mM none 0.27 0.03 
fusidic acid 
EF-2 2 mM fusidic 0.50 0.03 
acid 
-.- ____ ____ 
N-Ac-[‘~C]P~~-~RNA was bound to ribosomes in an incubation mixture containing40S 
and 60s ribosomal subunits, poly(U), an energy generating system and N-Ac-[‘~C]P~~- 
tRNA at 24 mM MgCl,. Where indicated fusidic acid, EF-2 or EF-2, inactivated by NAD 
and diphtheria toxin were added. This is called the first step of the incubation. After 45 
min puromycin and KC1 (final concentration 1 mM and 0,2 M respectively) were added 
and fusidic acid only in Exp. 5, and the incubation was continued for another 15 min. 
This is called the second step of the incubation. Binding and formation of N-A~-[‘~clPhe- 
puromycin were measured as described. Also for further details see references [25] and 
(261. 
Both fusidic acid and pretreatment of EF-2 with 
diphtheria toxin inhibited the reaction of N-AC- [ l4 C] 
Phe-tRNA and puromycin. An explanation for this 
observation is that both inhibitors restrain N-Ac- 
[‘“Cl Phe-tRNA on the ribosomal acceptor site. This 
would mean that fusidic acid does not allow under 
these circumstances one additional round of transloca- 
tion. In order to subject this assumption to a further 
proof, the influence of fusidic acid on the peptidyl- 
transferase was tested. 
It appeared that, when fusidic acid was added to 
an incubation mixture containing ribosomes which 
had bound N-AC- [ l4 C] Phe-tRNA in a puromycin 
reactive site, it completely inhibited the reaction of 
this N-AC- [ l4 C] Phe-tRNA with puromycin (table 2, 
exp. 4). 
The rather high fusidic acid concentration of 2 mM 
was suspected to have had a non-specific inhibitory 
effect on the peptidyl-transferase mediated reaction 
of N-AC- [‘“Cl Phe-tRNA with puromycin. Therefore 
lower fusidic acid concentrations were tested. Table 2 
demonstrates that the inhibitions of the peptidyl- 
transferase reaction is also found at lower concentra- 
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tions. At 0.5 mM this reaction is even more sensitive to 
fusidic acid than the EF-2 mediated binding of N-Ac- 
[14C] Phe-tRNA. 
Table 2 
Effect of fusidic acid concentration on binding and release by 
puromycin of N-A~-[‘~cjphe-tRNA 
EF-2 Fusidic acid Molecules boundMolecules released 
concentration per ribosome per ribosome 
(mM) 
_ 0 0.155 not determined 
+ 0 0.250 0.090 
+ 0.1 0.235(15%) 0.070(20%) 
f 0.5 0.230(20%) 0.038(60%) 
+ 1 0.190(65%) 0.033(65%) 
+ 2 0.155(100%) 0.018(80%) 
N-Ac-[‘~C]P~~-~RNA was bound to ribosomes, fusidic acid 
was added during the binding reaction and in parallel incuba- 
tions only during the puromycin reaction. The formation of 
N-AC-[‘4C]Phe-puromycin was measured 125,261. In 
parentheses the percentage inhibition of the EF-2 mediated 
additional binding and of the reaction with puromycin are 
given. 
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4. Discussion 
From experiments designed to answer questions 
about the mode of action of fusidic acid a hitherto 
not found inhibition of the peptidyl-transferase reaction 
by fusidic acid emerged. It appeared that 80s riboso- 
mes from yeast are inhibited with respect to the 
reaction of donor site bound N-AC- [r4 C] Phe-tRNA 
and puromycin. 
This inhibition is probably not a direct inhibition 
of the peptidyl-transferase reaction. At least if we 
assume that this reaction can be measured by the so 
called fragment reaction in the presence of 30% alcohol. 
It has been found [27, and our own unpublished 
results] that under these circumstances fusidic acid 
has no inhibitory activity on eukaryotic ribosomes. 
Our results are in contradiction with these obtain- 
ed for 70s ribosomes [ 121. It seems that there is a 
difference in fusidic acid sensitivity between prokary- 
otic and eukaryotic ribosomes in such a way that the 
presence of the EF-2-fusidic acid-GDP complex 
impairs the peptidyl-transferase activity. 
Thus caution is needed in interpreting effects of 
fusidic acid for the elucidation of ribosomal function- 
ing. 
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